i-Tracker anti-Golimumab
Product Description
i-Tracker anti-Golimumab is an automated assay intended for the quantitative measurement of Anti Golimumab antibodies (anti-drug antibodies: ADAb) in human serum or plasma samples.
- Innovative CLIA technology
- Quantitative measurement of drug and anti-drug antibodies
- First results in less than 35 minutes; 60 results/hour
- Validated on princeps and biosimilars
- Controls and calibrators included
-
- SandbornWJ & al. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146:85-95.
- SandbornWJ & al. Subcutaneous golimumab maintains clinical response in patients with moderate-tosevere ulcerative colitis. Gastroenterology. 2014;146:96-109.e1. 4.
- Adedokun OJ & al. Immunogenicity of golimumab and its clinical relevance in patients with ulcerative colitis. Inflamm Bowel Dis. 2019;25:1532-1540.
- DetrezI, & al. Variability in golimumab exposure: a ‘Real-Life’ observational study in active ulcerative colitis. J Crohns Colitis. 2016;10:575-581.
- Philip G, & al. Early dose optimisation of golimumab in nonresponders to induction treatment for ulcerative colitis is effective and supported by pharmacokinetic data. J Crohns Colitis. 2019;13:1257-1264.
- Samaan MA & al. Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study. Aliment Pharmacol Ther. 2020 Jul;52(2):292-302
- Product Code: CTG 003-50
- Number of Tests: 50
- Sample Type: Serum or plasma
- Sample Volume: 100 µL
- Assay Range: 10 - 2000 ng/mL
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| i-Tracker Golimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Infliximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Adalimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Certolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Rituximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |